ClinicalTrials.gov
ClinicalTrials.gov Menu

HIV/STD Safer Sex Skills Groups for Women in Drug Treatment Programs - 1

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00084188
Recruitment Status : Completed
First Posted : June 9, 2004
Last Update Posted : January 12, 2017
Sponsor:
Information provided by:
National Institute on Drug Abuse (NIDA)

Study Description
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of this study is to look at a program for women in drug abuse treatment designed to reduce Human Immunodeficiency Virus/Sexually Transmitted Disease (HIV/STD) risk behaviors and reduce unprotected sexual risk behavior.

Condition or disease Intervention/treatment Phase
Behavior Therapy Behavioral: Behavior Therapy Phase 3

Detailed Description:

The proposed trial is intended to test the effectiveness of a proven, manual driven, five-session safer sexual skills building group (SSB) intervention (Schilling et al., 1991; El Bassel and Schilling, 1992) for female patients in MMTP or in drug-free outpatient treatment. The effects of SSB will be compared to a standard group HIV education session (HE).

This study uses a 2-group, randomized, parallel-group design to compare a five-session safer sexual skills building group to a single 60-min HIV education session (control condition). The control condition is designed to standardize and simulate the usual care at community clinics.


Study Design
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Interventional  (Clinical Trial)
Enrollment : 541 participants
Primary Purpose: Treatment
Official Title: HIV/STD Safer Sex Skills Groups for Women in Drug Treatment Programs
Study Start Date : May 2004
Actual Primary Completion Date : October 2005
Actual Study Completion Date : October 2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: HIV/AIDS
U.S. FDA Resources

Arms and Interventions
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. AIDS risk behavior

Eligibility Criteria
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 99 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria
Adult females (18 years of age or older) in drug abuse treatment at participating Community Treatment Programs are invited to participate.
Contacts and Locations
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00084188


Locations
United States, California
Baart Cdp
Los Angeles, California, United States, 90057
United States, Connecticut
Hartford Dispensary
New Britain, Connecticut, United States, 06051
United States, New York
Staten Island University Hospital
Staten Island, New York, United States, 10309
United States, North Carolina
Addiction Drug Services
Greensboro, North Carolina, United States, 27401
South Light - Life Plus
Raleigh, North Carolina, United States, 27604
South Light - Wakeview
Raleigh, North Carolina, United States, 27604
United States, Ohio
Comprehensive Addiction Services System
Toledo, Ohio, United States, 43620
United States, Pennsylvania
The Consortium
Philadelphia, Pennsylvania, United States, 19104
Thomas Jefferson Intensive Sub. Abuse TP
Philadelphia, Pennsylvania, United States, 19107
United States, South Carolina
LRADAC-Lexington-Richmond Alcohol & Drug Council
Columbia, South Carolina, United States, 29204
United States, Washington
Evergreen Treatment Services
Seattle, Washington, United States, 98134 1618
United States, West Virginia
Prestera Center for Mental Health Svcs.
Huntington, West Virginia, United States, 25704
Sponsors and Collaborators
New York State Psychiatric Institute
Investigators
Principal Investigator: Susan Tross, Ph.D. New York State Psychiatric Institute
More Information
Go to 
Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Susan Tross, Ph.D., New York State Psychiatric Institute
ClinicalTrials.gov Identifier: NCT00084188     History of Changes
Other Study ID Numbers: NIDA-CTN-0019-1
First Posted: June 9, 2004    Key Record Dates
Last Update Posted: January 12, 2017
Last Verified: October 2016

Keywords provided by National Institute on Drug Abuse (NIDA):
behavioral intervention